Scoop: Led by for­mer Trump of­fi­cial, Al­te­sa Bio­Sciences rais­es $35M for an­tivi­rals, re­cruits Mon­cef Slaoui to board

Al­te­sa Bio­Sciences has raised a $35 mil­lion Se­ries A from undis­closed in­vestors, ac­cord­ing to an SEC fil­ing from Ju­ly. The com­pa­ny de­vel­ops an­tivi­ral drugs for chron­ic ob­struc­tive pul­monary dis­ease from virus­es that cause the com­mon cold.

The Col­lege Park, GA-based start­up is led by Brett Giroir, the for­mer as­sis­tant sec­re­tary for health in the De­part­ment of Health and Hu­man Ser­vices dur­ing the Trump ad­min­is­tra­tion, act­ing FDA com­mis­sion­er and ad­mi­ral.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER